• to reduced the potential risk of severe cardiovascular (heart and blood vessel) issues in adults with variety 2 diabetes and heart problemsIn Oct 2024, Novo Nordisk released a analyze on scientific journal Mother nature about a novel glucose-delicate insulin NNC2215 which can lower the risk of hypoglycemia in animal designs.[sixty seven]The sub… Read More